Pathogenesis of hepatocellular carcinoma

Clinics in Liver Disease

Volumn 5, Issue 1, 2001, Pages 69-85

  Macdonald, Graeme A ^b  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGING; CANCER MODEL; CANCER RISK; ENVIRONMENTAL FACTOR; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HOST; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PATHOGENESIS; REVIEW; RISK FACTOR; VIRUS PATHOGENESIS;

EID: 0035143880     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(05)70154-9     Document Type: Article

References (106)

1. Iron-induced oxidative DNA damage and its repair in primary rat hepatocyte culture
2. Excess risk of primary liver cancer in patients with diabetes mellitus
3. Cancer risk in patients with diabetes mellitus
4. Clonal analysis of regenerative nodules in hepatitis C virus-induced liver cirrhosis
5. Clonal analysis of precancerous lesion of hepatocellular carcinoma
6. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas
7. DNA ploidy study of resected hepatocellular carcinoma in cirrhotic liver
8. Hepatocellular carcinoma and cirrhosis: A review of their relative incidence in a 25-year period in the Florence area
9. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan
10. Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers
11. Primary hepatic cancer and liver cirrhosis. Autopsy study covering fifty years
12. Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype
13. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
14. Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma
15. Hepatocellular carcinoma and hepatic cirrhosis in the west of Scotland: A 25-year necropsy review
16. Computer program for the analysis of mutational spectra: Application to p53 mutations
17. Detection of bulky DNA lesions in the liver of patients with Wilson's disease and primary haemochromatosis
18. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group
19. Pathogenic factors in cirrhosis with and without hepatocellular carcinoma: A multicenter Italian study
20. Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors
21. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity
22. Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor
23. NIH conference. Hepatocellular carcinoma
24. Primary carcinoma of the liver: A study of 100 cases among 48,900 necroposies
25. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer
26. Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma
27. Relative incidence of primary liver cancer in cirrhosis in Austria. Etiological considerations
28. Allelotype study of primary hepatocellular carcinoma
29. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China
30. Isolation of a candidate tumor suppressor gene on chromosome 8p21.3-p22 that is homologous to an extracellular domain of the PDGF receptor beta gene
31. Hepatocellular carcinoma mutation [letter]
32. p73 is up-regulated in a subset of hepatocellular carcinomas
33. p53 mutations in human cancers
34. Mutational hotspot in the p53 gene in human hepatocellular carcinomas
35. Telomerase activity and telomere length in human hepatocellular carcinoma
36. Telomerase activity in precancerous hepatic nodules
37. Hepatocellular carcinoma in liver cirrhosis: A prospective study
38. Reduction of telomeric repeats as a possible predictor for development of hepatocellular carcinoma: Convenient evaluation by slot-blot analysis
39. Overexpression of human insulin receptor substrate 1 induces cellular transformation with activation of mitogen-activated protein kinases
40. Hepatocellular carcinoma in Great Britain: Influence of age, sex, HBsAg status, and aetiology of underlying cirrhosis
41. Surgical significance of telomerase activity in noncancerous liver tissue from patients with hepatocellular carcinoma
42. Clinical implications of telomerase activity in resected hepatocellular carcinoma
43. Possible role of oxidative damage in metal-induced carcinogenesis
44. Microsatellite instability in human hepatocellular carcinoma: Relationship to p53 abnormalities
45. Clinical, pathologic, and etiologic heterogeneity in hepatocellular carcinoma: Evidence from southern Africa
46. Increased expression of the insulin-like growth factor 1 (IGF-I) receptor gene in hepatocellular carcinoma cell lines: Implications of IGF-I receptor gene activation by hepatitis B virus X gene product
47. Telomerase activity in hepatocellular carcinoma and adjacent liver tissues
48. Frequent loss in chromosome 8p loci in liver cirrhosis accompanying hepatocellular carcinoma
49. Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease
50. Low incidence of p53 mutations in European hepatocellular carcinomas with heterogeneous mutation as a rare event
51. Accumulation of genetic changes during development and progression of hepatocellular carcinoma: Loss of heterozygosity of chromosome arm 1p occurs at an early stage of hepatocarcinogenesis
52. Diabetes mellitus and the risk of primary liver cancer
53. Diabetes mellitus and primary hepatocellular carcinoma
54. Hepatitis B vaccination and hepatocellular carcinoma in Taiwan
55. Insulin-like growth factors and cancer
56. The p53 tumor suppressor gene
57. Activation of p53 tumor suppressor by hepatitis C virus core protein
58. Microsatellite instability and loss of heterozygosity at DNA mismatch repair gene loci occurs during hepatic carcinogenesis
59. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization
60. New link found between p53 and DNA repair
61. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1
62. Liver cirrhosis and liver cancer: A study of their relationship in 2563 autopsies
63. Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis
64. Insulin-like growth factor II receptor as a multifunctional binding protein
65. Core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice
66. Telomerase reverse transcriptase mRNA expression and telomerase activity in hepatocellular carcinoma
67. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma
68. Comprehensive allelotyping of human hepatocellular carcinoma
69. Cloning and increased expression of an insulin receptor substrate-1-like gene in human hepatocellular carcinoma
70. Quantitative analysis and in situ localization of human telomerase RNA in chronic liver disease and hepatocellular carcinoma
71. Telomere changes in human hepatocellular carcinomas and hepatitis virus infected noncancerous livers
72. Numerical chromosome aberrations in hepatocellular carcinoma detected by fluorescence in situ hybridization
73. Telomerase is strongly activated in hepatocellular carcinoma but not in chronic hepatitis and cirrhosis
74. Estimates of the worldwide frequency of twelve major cancers
75. Relationship between loss of heterozygosity of tumor suppressor genes and histologic differentiation in hepatocellular carcinoma
76. Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens
77. Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus core protein
78. Hepatitis C virus core protein represses p21WAF1/Cip1/Sid1 promoter activity
79. Transcriptional repression of p53 promoter by hepatitis C virus core protein
80. Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein
81. Loss of heterozygosity on chromosome 16 in hepatocellular carcinoma
82. Chromosomal aberrations in human hepatocellular carcinomas associated with hepatitis C virus infection detected by comparative genomic hybridization
83. Frequent microsatellite instability in post hepatitis B viral cirrhosis
84. Microsatellite instability in European hepatocellular carcinoma
85. Increased expression of insulin-like growth factor 2 in hepatocellular carcinoma is primarily regulated at the transcriptional level
86. Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma
87. Telomerase activity in human liver tissues: Comparison between chronic liver disease and hepatocellular carcinomas
88. Activation of nuclear factor kappaB in hepatitis C virus infection: Implications for pathogenesis and hepatocarcinogenesis
89. Association of cumulative allelic loss with tumor aggressiveness in hepatocellular carcinoma
90. Neoplastic transformation induced by insulin receptor substrate-1 overexpression requires an interaction with both Grb2 and Syp signaling molecules
91. A long-term follow-up study on risk factors for hepatocellular carcinoma among Japanese patients with liver cirrhosis
92. A carboxy-terminal truncated insulin receptor substrate-1 dominant negative protein reverses the human hepatocellular carcinoma malignant phenotype
93. Insulin receptor substrate 1 overexpression in human hepatocellular carcinoma cells prevents transforming growth factor beta1-induced apoptosis
94. Telomere length in human liver diseases
95. p53 mutations in British patients with hepatocellular carcinoma: Clustering in genetic hemochromatosis
96. Genetic diagnostic test of hepatocellular carcinoma by telomerase catalytic subunit mRNA
97. Failure to detect genetic alteration of the mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) gene in hepatocellular carcinomas in Japan
98. Loss of somatic heterozygosity in hepatocellular carcinoma
99. Mechanism of activation of the TGF-beta receptor
100. Mannose 6-phospate insulin-like growth factor-II receptor: A tumor suppressor gene in human liver cancer associated with viral hepatitis and cirrhosis
101. Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis
102. Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas
103. Nuclear factor kappaB and hepatitis C-Is there a connection?
104. Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California
105. Risk factors in development of hepatocellular carcinoma in cirrhosis: Prospective study of 613 patients
106. Chromosomal aberrations in hepatocellular carcinomas: Relationship with pathological features